BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 18472252)

  • 1. Low adiponectin levels in primary hypertriglyceridemic male patients.
    Gómez Rosso L; Meroño T; Benítez MB; López G; Giunta G; D'Ambrosio ML; Wikinski R; Cuniberti L; Brites F
    Nutr Metab Cardiovasc Dis; 2009 Feb; 19(2):135-9. PubMed ID: 18472252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating osteoprotegerin is correlated with lipid profile, insulin sensitivity, adiponectin and sex steroids in an ageing male population.
    Gannagé-Yared MH; Fares F; Semaan M; Khalife S; Jambart S
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):652-8. PubMed ID: 16712667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adiponectin is an important determinant of apoA-I catabolism.
    Vergès B; Petit JM; Duvillard L; Dautin G; Florentin E; Galland F; Gambert P
    Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1364-9. PubMed ID: 16574896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesteryl ester transfer protein in metabolic syndrome.
    Sandhofer A; Kaser S; Ritsch A; Laimer M; Engl J; Paulweber B; Patsch JR; Ebenbichler CF
    Obesity (Silver Spring); 2006 May; 14(5):812-8. PubMed ID: 16855190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the relationship of leptin, high-sensitivity C-reactive protein, adiponectin, insulin, and uric acid to metabolic syndrome in lean, overweight, and obese young females.
    Abdullah AR; Hasan HA; Raigangar VL
    Metab Syndr Relat Disord; 2009 Feb; 7(1):17-22. PubMed ID: 19025443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between hypoadiponectinemia and cardiovascular risk factors in nonobese healthy adults.
    Im JA; Kim SH; Lee JW; Shim JY; Lee HR; Lee DC
    Metabolism; 2006 Nov; 55(11):1546-50. PubMed ID: 17046559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adiponectin and its correlates of cardiovascular risk in young adults: the Bogalusa Heart Study.
    Patel DA; Srinivasan SR; Xu JH; Chen W; Berenson GS
    Metabolism; 2006 Nov; 55(11):1551-7. PubMed ID: 17046560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome, insulin resistance and adiponectin level in patients with chronic hepatitis C.
    Grigorescu M; Radu C; Crişan D; Grigorescu MD; Serban A; Neculoiu D; Rusu M; Acalovschi M
    J Gastrointestin Liver Dis; 2008 Jun; 17(2):147-54. PubMed ID: 18568135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity.
    Hung J; McQuillan BM; Thompson PL; Beilby JP
    Int J Obes (Lond); 2008 May; 32(5):772-9. PubMed ID: 18253163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postprandial plasma adiponectin decreases after glucose and high fat meal and is independently associated with postprandial triacylglycerols but not with -- 11388 promoter polymorphism.
    Rubin D; Helwig U; Nothnagel M; Lemke N; Schreiber S; Fölsch UR; Döring F; Schrezenmeir J
    Br J Nutr; 2008 Jan; 99(1):76-82. PubMed ID: 17663805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Waist circumference and serum adiponectin levels in obese and non-obese postmenopausal women.
    Milewicz A; Jedrzejuk D; Dunajska K; Lwow F
    Maturitas; 2010 Mar; 65(3):272-5. PubMed ID: 20004538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hypertriglyceridemic waist phenotype versus the National Cholesterol Education Program-Adult Treatment Panel III and International Diabetes Federation clinical criteria to identify high-risk men with an altered cardiometabolic risk profile.
    Blackburn P; Lemieux I; Alméras N; Bergeron J; Côté M; Tremblay A; Lamarche B; Després JP
    Metabolism; 2009 Aug; 58(8):1123-30. PubMed ID: 19481769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of antihypertensive agents on plasma adiponectin levels in hypertensive patients with metabolic syndrome.
    Yilmaz MI; Sonmez A; Caglar K; Celik T; Yenicesu M; Eyileten T; Acikel C; Oguz Y; Yavuz I; Vural A
    Nephrology (Carlton); 2007 Apr; 12(2):147-53. PubMed ID: 17371337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HOMA-IR and non-HDL-C as predictors of high cholesteryl ester transfer protein activity in patients at risk for type 2 diabetes.
    Coniglio RI; Meroño T; Montiel H; Malaspina MM; Salgueiro AM; Otero JC; Ferraris R; Schreier L; Brites F; Gómez Rosso L
    Clin Biochem; 2012 May; 45(7-8):566-70. PubMed ID: 22366373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of adiponectin with procollagen type I carboxyterminal propeptide in non-diabetic essential hypertension.
    Tsai WC; Lin CC; Chen JY; Huang YY; Lee CH; Li WT; Weng CM; Chen JH
    Blood Press; 2008; 17(4):233-8. PubMed ID: 18671144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High adiponectin and TNF-alpha levels in moderate drinkers suffering from liver steatosis: comparison with non drinkers suffering from similar hepatopathy.
    Stejskal D; Růzicka V; Fanfrdlová G; Kolár V; Bartek J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Jun; 149(1):93-9. PubMed ID: 16170395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of indices of insulin resistance with metabolic syndrome classifications to predict the development of impaired fasting glucose in overweight and obese subjects: a 3-year prospective study.
    Shand BI; Scott RS; Lewis JG; Elder PA; Frampton CM
    Int J Obes (Lond); 2009 Nov; 33(11):1274-9. PubMed ID: 19721448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased high-density lipoprotein cholesterol is associated with inflammation and insulin resistance in non-diabetic haemodialysis patients.
    Peng YS; Chiu YL; Chen HY; Yang JY; Lai CF; Hsu SP; Pai MF
    Nephrology (Carlton); 2010 Oct; 15(7):692-9. PubMed ID: 21040164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum adiponectin and metabolic parameters in HIV-1-infected patients after substitution of nevirapine for protease inhibitors.
    Petit JM; Duong M; Masson D; Buisson M; Duvillard L; Bour JB; Brindisi MC; Galland F; Guiguet M; Gambert P; Portier H; Vergès B
    Eur J Clin Invest; 2004 Aug; 34(8):569-75. PubMed ID: 15305892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pravastatin does not affect insulin sensitivity and adipocytokines levels in healthy nondiabetic patients.
    Gannagé-Yared MH; Azar RR; Amm-Azar M; Khalifé S; Germanos-Haddad M; Neemtallah R; Halaby G
    Metabolism; 2005 Jul; 54(7):947-51. PubMed ID: 15988706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.